NTRK1 and arthritic joint disease: In patients with chronic arthritis, TrkA expression was significantly reduced in peripheral blood and synovial fluid mononuclear cells, resulting in a loss of inhibitory effect of nerve growth factor on inflammatory cytokine release, suggesting that inhibition of the nerve growth factor-TrkA signalling pathway may instead adversely affect patients with arthritis (Prencipe et al., 2014).